Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11866491
Antibody for binding to interleukin 4 receptor
granted -
US 11865286
Active agent delivery devices and methods of using the same
granted -
US 11865117
Pharmaceutical compositions comprising meloxicam
granted -
US 11865179
Progesterone formulations having a desirable PK profile
granted -
US 11865168
Compositions and methods for treating bacterial infections
granted -
US 11866701
Complement component C3 iRNA compositions and methods of use thereof
granted -
US 11866450
Modulators of Cystic Fibrosis Transmembrane Conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators
granted -
US 11866439
Ion channel modulators
granted -
US 11866411
Therapeutic compounds and compositions
granted -
US 11866488
Compositions comprising an anti-metallothionein antibody and a pancreatic cell targeting moiety
granted -
US 11866444
Oxabicycloheptane prodrugs
granted -
US 11866476
Masked IL-2-Fc fusion polypeptides
granted -
US 11865166
Nucleic acid encoding optimized immunogenic peptide that targets follicle stimulating hormone receptor
granted -
US 11866794
Cas-ready mouse embryonic stem cells and mice and uses thereof
granted -
US 11866502
Anti-FGFR2 antibodies and methods of use thereof
granted -
US 11866515
Hemiasterlin derivatives for conjugation and therapy
granted -
US 11866442
Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway
granted -
US 11866688
Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 11866507
Multispecific polypeptide constructs having constrained CD3 binding and methods of using the same
granted -
US 11865174
Universal vaccine platform
granted -
US 11866418
Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
granted -
US 11865172
Materials and methods for respiratory disease control in canines
granted -
US 11866446
Inhibitors of APOL1 and methods of using same
granted -
US 11865155
Plant extract obtained from Morus plant leaves which has an IC50 value to inhibit a-glucosidase I at a concentration of less than 90 uG/ml, compositions containing same, method of extraction and uses thereof
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.